Outset Medical's (OM) Prolonged FDA Review, Creates a Speedbump, PT Cut to $30 at Stifel
Tweet Send to a Friend
Stifel analyst Rick Wise lowered the price target on Outset Medical Inc. (NASDAQ: OM) to $30.00 (from $55.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
